In a groundbreaking collaborative effort, academic researchers, industry leaders, and charities have joined forces to combat Type 1 Diabetes (T1D) with the support of a €23 million grant from the Innovative Health Initiative (IHI). EDENT1FI is a collaboration comprised of 28 partners from 12 countries, including the Center for Regenerative Therapies Dresden (CRTD) at TU Dresden in cooperation with the Clinic and Polyclinic for Pediatrics and Adolescent Medicine at the University Hospital Carl Gustav Carus Dresden.
from Pressemitteilungen – idw – Informationsdienst Wissenschaft https://ift.tt/wWosOPL